24
Participants
Start Date
April 7, 2016
Primary Completion Date
March 28, 2018
Study Completion Date
March 28, 2018
Adalimumab
Adalimumab
Sodersjukhuset, Stockholm
Karolinska Univ Sjukhuset, Solna
Norrlands Universitetssjukhus, Umeå
Universitetssjukhuset Linköping, Linkoping
Hallands Hospital Halmstad, Halmstad
Blekinge Hospital, Karlskrona
Skaraborgs Hospital, Skövde
Kungsholmens Hudklinik, Stockholm
Danderyd Hospital, Stockholm
Trelleborg Hospital, Trelleborg
Akademiska sjukhuset, Uppsala
Lead Sponsor
AbbVie
INDUSTRY